David Juurlink

David Juurlink (born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internal medicine doctor. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research.[1] He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol[2] and fentanyl.[3][4] In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in the New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.[5]

References
  1. "We are Sunnybrook". The Globe and Mail. 7 May 2011. Retrieved 24 June 2017.
  2. Kirkup, Kristy (26 February 2017). "Health Canada's position on opioid Tramadol is indefensible: doctor". The Globe and Mail. Retrieved 24 June 2017.
  3. Kirkey, Sharon (7 April 2016). "Doctors' reckless prescribing of fentanyl largely to blame for deadly overdoses: expert". National Post. Retrieved 24 June 2017.
  4. "Dr. David Juurlink says colleagues must accept blame for fentanyl ODs". CBC News. 24 August 2015. Retrieved 24 June 2017.
  5. "Opioid crisis: The letter that started it all". BBC News. 3 June 2017. Retrieved 24 June 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.